C

Carterra

87 employees

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies.

Basic info

Industry

biotechnology research

Sectors

hybridoma
Biotechnology
immunooncology
kinetic characterization
B Cell Cloning
biotechnology
phage display
hybridoma screening
immunity monitoring
protein-protein
serology
infectious disease
vaccine research
epitope mapping
Developer Platform
antibody development
epitope binning
cancer
covid19
label-free
Information Services
B-Cell Enrichment
SPR
neuroscience
antibody discovery
Medical

Date founded

2005

Funding rounds raised

Total raised

$8.1M

from 5 investors over 5 rounds

C

Carterra raised $8.1M on December 14, 2020

Investors: Ballast Point Ventures and Telegraph Hill Partners

C

Carterra raised $6M on January 14, 2020

Investors: Ballast Point Ventures and Telegraph Hill Partners

C

Carterra raised $200K on January 25, 2012

Investors: -

FAQ